. . . "0010-8650" . "Transapik\u00E1ln\u00ED implantace aort\u00E1ln\u00ED chlopn\u011B p\u0159i \u0159e\u0161en\u00ED degenerativn\u00ED aort\u00E1ln\u00ED sten\u00F3zy" . "Brtko, Miroslav" . "Transapical aortic valve implantation in patients with aortic valve stenosis"@en . . "Transapik\u00E1ln\u00ED implantace aort\u00E1ln\u00ED chlopn\u011B p\u0159i \u0159e\u0161en\u00ED degenerativn\u00ED aort\u00E1ln\u00ED sten\u00F3zy"@cs . "\u0160\u0165\u00E1sek, Josef" . "293261" . . "\u00DAvod: V pr\u00E1ci popisujeme na\u0161e prvn\u00ED zku\u0161enosti s katetrovou transapik\u00E1ln\u00ED implantac\u00ED aort\u00E1ln\u00ED chlopenn\u00ED bioprot\u00E9zy Edwards Sapien. Metody a v\u00FDsledky: Z 12 pacient\u016F l\u00E9\u010Den\u00FDch transkatetrovou implantac\u00ED aort\u00E1ln\u00ED chlopn\u011B (TAVI) jsme doposud vyu\u017Eili transapik\u00E1ln\u00ED p\u0159\u00EDstupov\u00E9 cesty u p\u011Bti pacient\u016F (sedmkr\u00E1t byla provedena transfemor\u00E1ln\u00ED implantace). Nikdo z pacient\u016F v souvislosti s v\u00FDkonem nezem\u0159el. Periprocedur\u00E1ln\u00ED a 30denn\u00ED mortalita je v cel\u00E9m 12\u010Dlenn\u00E9m souboru nulov\u00E1. V\u0161ichni nemocn\u00ED l\u00E9\u010Den\u00ED transapik\u00E1ln\u00ED p\u0159\u00EDstupovou cestou (TAP-AVI) p\u0159e\u017E\u00EDvaj\u00ED a jejich klinick\u00FD stav se zlep\u0161il. Centr\u00E1ln\u00ED regurgitace u jednoho z na\u0161ich pacient\u016F byla \u0159e\u0161ena strategi\u00ED %22valve-in-valve%22. V \u010Dl\u00E1nku popisujeme pracovn\u00ED postup a t\u00E9\u017E \u0159e\u0161en\u00ED komplikac\u00ED, se kter\u00FDmi jsme se setkali. Z\u00E1v\u011Br: Transapik\u00E1ln\u00ED implantace aort\u00E1ln\u00ED chlopn\u011B je dnes ji\u017E zavedenou l\u00E9\u010Debnou metodou s dobr\u00FDmi v\u00FDsledky a p\u0159ijateln\u00FDm rizikem. Na\u0161e inici\u00E1ln\u00ED zku\u0161enost s touto technikou je p\u0159\u00EDzniv\u00E1"@cs . "Transapical aortic valve implantation; Valvular prosthesis; Aortic stenosis"@en . . . . "RIV/00216208:11150/10:10057415!RIV11-MZ0-11150___" . "Holubec, Tom\u00E1\u0161" . . . "Transapik\u00E1ln\u00ED implantace aort\u00E1ln\u00ED chlopn\u011B p\u0159i \u0159e\u0161en\u00ED degenerativn\u00ED aort\u00E1ln\u00ED sten\u00F3zy"@cs . . "Transapical aortic valve implantation in patients with aortic valve stenosis"@en . "[A07D54DA8B74]" . "Cor et Vasa" . . . . . "Bis, Josef" . "5-6" . . "11150" . "52" . "Polansk\u00FD, Pavel" . "Introduction: Paper describes our initial experience with transapical aortic valve implantation (TAP-AVI) the Edwards Sapien system. Methods and results: Out of 12 patients treated with transcatheter aortic valve implantation (TAVI), we have so far used transapical aortic valve implantation (TAP-AVI) in fi ve patients (transfemoral implantation was used in seven cases). Periprocedural and 30-day mortality was zero in the whole group of our 12 patients. All patients treated using TAP-AVI have survived with improved clinical status. Central regurgitation in one case was managed using the %22valve-in-valve%22 strategy. We describe the procedure of implantation and possibility to manage complications we encountered. Conclusion: Transapical aortic valve implantation is a safe therapeutical method with good results and acceptable risk. Our initial results of the transapical approach are encouraging"@en . "8"^^ . . . . "P(NS9741)" . "7"^^ . "5"^^ . "CZ - \u010Cesk\u00E1 republika" . "Voj\u00E1\u010Dek, Jan" . "Harrer, Jan" . "RIV/00216208:11150/10:10057415" . "\u00DAvod: V pr\u00E1ci popisujeme na\u0161e prvn\u00ED zku\u0161enosti s katetrovou transapik\u00E1ln\u00ED implantac\u00ED aort\u00E1ln\u00ED chlopenn\u00ED bioprot\u00E9zy Edwards Sapien. Metody a v\u00FDsledky: Z 12 pacient\u016F l\u00E9\u010Den\u00FDch transkatetrovou implantac\u00ED aort\u00E1ln\u00ED chlopn\u011B (TAVI) jsme doposud vyu\u017Eili transapik\u00E1ln\u00ED p\u0159\u00EDstupov\u00E9 cesty u p\u011Bti pacient\u016F (sedmkr\u00E1t byla provedena transfemor\u00E1ln\u00ED implantace). Nikdo z pacient\u016F v souvislosti s v\u00FDkonem nezem\u0159el. Periprocedur\u00E1ln\u00ED a 30denn\u00ED mortalita je v cel\u00E9m 12\u010Dlenn\u00E9m souboru nulov\u00E1. V\u0161ichni nemocn\u00ED l\u00E9\u010Den\u00ED transapik\u00E1ln\u00ED p\u0159\u00EDstupovou cestou (TAP-AVI) p\u0159e\u017E\u00EDvaj\u00ED a jejich klinick\u00FD stav se zlep\u0161il. Centr\u00E1ln\u00ED regurgitace u jednoho z na\u0161ich pacient\u016F byla \u0159e\u0161ena strategi\u00ED %22valve-in-valve%22. V \u010Dl\u00E1nku popisujeme pracovn\u00ED postup a t\u00E9\u017E \u0159e\u0161en\u00ED komplikac\u00ED, se kter\u00FDmi jsme se setkali. Z\u00E1v\u011Br: Transapik\u00E1ln\u00ED implantace aort\u00E1ln\u00ED chlopn\u011B je dnes ji\u017E zavedenou l\u00E9\u010Debnou metodou s dobr\u00FDmi v\u00FDsledky a p\u0159ijateln\u00FDm rizikem. Na\u0161e inici\u00E1ln\u00ED zku\u0161enost s touto technikou je p\u0159\u00EDzniv\u00E1" . "Transapik\u00E1ln\u00ED implantace aort\u00E1ln\u00ED chlopn\u011B p\u0159i \u0159e\u0161en\u00ED degenerativn\u00ED aort\u00E1ln\u00ED sten\u00F3zy" .